Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000117042 | SCV000151174 | uncertain significance | not provided | 2013-03-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000117042 | SCV000250409 | likely benign | not provided | 2020-10-07 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000117042 | SCV000511381 | likely benign | not provided | 2016-09-01 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Labcorp Genetics |
RCV001079137 | SCV000556070 | benign | Heterotopia, periventricular, X-linked dominant; Melnick-Needles syndrome; Oto-palato-digital syndrome, type II; Frontometaphyseal dysplasia | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313881 | SCV000739099 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-04-12 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Human Genetics, |
RCV000659655 | SCV000781498 | likely benign | Connective tissue disorder | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000199806 | SCV000856322 | likely benign | not specified | 2017-08-22 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000117042 | SCV000883907 | likely benign | not provided | 2023-09-26 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000117042 | SCV000893024 | likely benign | not provided | 2018-12-01 | criteria provided, single submitter | clinical testing | |
Johns Hopkins Genomics, |
RCV000117042 | SCV001469048 | likely benign | not provided | 2020-12-02 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV004584353 | SCV002506427 | uncertain significance | See cases | 2021-12-09 | criteria provided, single submitter | clinical testing | ACMG categories: PM1,PP3 |
Prevention |
RCV004529961 | SCV004738481 | likely benign | FLNA-related disorder | 2021-04-22 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000199806 | SCV005076251 | likely benign | not specified | 2024-04-14 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000117042 | SCV001928225 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000117042 | SCV001970170 | likely benign | not provided | no assertion criteria provided | clinical testing |